Navigation Links
RoundTable Healthcare Partners and Argon Medical Devices Complete Acquisition of Angiotech Pharmaceuticals' Interventional Products Business
Date:4/15/2013

LAKE FOREST, Ill., April 15, 2013 /PRNewswire/ -- RoundTable Healthcare Partners ("RoundTable"), an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that its portfolio company, Argon Medical Devices, Inc. ("Argon" or the "Company"), has completed the previously announced acquisition of the Interventional Products Business of Angiotech Pharmaceuticals, Inc. ("Angiotech").   The Interventional Products Business manufactures and markets disposable and re-usable biopsy products for the diagnosis of cancer, drainage catheter products, and vascular interventional products.

The acquisition of the Interventional Products Business bolsters Argon's existing portfolio of interventional vascular products, adds additional biopsy product lines, and further leverages the Company's sales force within core call points.  As part of the transaction, Argon will also acquire three dedicated manufacturing facilities in Wheeling, IL; Gainesville, FL; and Rochester, NY.  Argon currently manufactures its products in facilities in Athens, TX and Singapore.

"The acquisition of the Interventional Products Business is another step forward in expanding our portfolio to offer our customers a greater array of physician preference products," said Michael Hudson , CEO of Argon.  "We are delighted to be reunited with this business and look forward to positioning the combined company for significant growth."

The Interventional Products Business was created by RoundTable in 2003 as part of its American Medical Instruments Holdings, Inc. ("AMIH") investment. The AMIH business was run by Argon's current management team including: Michael Hudson , Argon's CEO; Richard Adloff , Argon's CFO; and George Leondis , Argon's President. AMIH combined the formerly independent Manan Medical, MD Tech, PBN Medical, and American Medical Instruments into a consolidated operating unit. Angiotech acquired the Interventional Products Business from RoundTable in 2006 as a part of its purchase of AMIH.

"We are extremely excited to have closed this transaction and to invest in this business again," said Joseph Damico , Founding Partner and Co-Chairman of RoundTable.  "We look forward to working closely with Argon and its employees to integrate these two complementary businesses."

As part of the transaction, RoundTable facilitated the successful completion of new senior credit facilities and a private placement of subordinated notes.  The senior credit facilities were led by GE Commercial Finance Healthcare Financial Services and Ares Management. Argon's subordinated notes were acquired by RoundTable Healthcare Capital Partners II ("Capital Fund II"), RoundTable's second captive subordinated debt fund.  Capital Fund II is a dedicated subordinated debt fund that makes fixed rate subordinated debt investments alongside the equity investments of RoundTable's equity funds. RoundTable and certain other investors made an equity investment in Argon as part of the transaction.

About RoundTable Healthcare Partners
RoundTable Healthcare Partners, based in Lake Forest, IL, is an operating-oriented private equity firm focused exclusively on the healthcare industry.  RoundTable partners with companies that can benefit from its extensive industry relationships and proven operating and transaction expertise.  RoundTable has established a successful track record of working with owner/founders, family companies, management teams, entrepreneurs and corporate partners who share a vision and believe in the value creation potential of its partnership model.  RoundTable currently manages $1.9 billion in capital, including three equity funds totaling $1.5 billion and two subordinated debt funds totaling $400 million.  More information about RoundTable Healthcare Partners can be found at www.roundtablehp.com.

About Argon Medical Devices
Founded in 1972, Argon is a global manufacturer of specialty medical products headquartered in Plano, Texas. Argon offers a broad line of medical devices for Interventional Radiology, Vascular Surgery, Interventional Cardiology, and Critical Care procedures. Current products include the Option™ Retrievable Inferior Vena Cava Filter, Cleaner Rotational Thrombectomy System, and UltraStream™ Chronic Dialysis Catheter. Argon also offers a complete line of PICC and midline catheters, endomyocardial biopsy forceps, introducer sheaths, pressure transducers, and other vascular products. The Company's products are sold globally through a combination of direct sales representatives and premier specialty distributors. For more information on Argon, please visit www.argonmedical.com.


'/>"/>
SOURCE RoundTable Healthcare Partners
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Contract Manufacturer RMI hosts Central Indiana Jobs Roundtable with U.S. Senator Joe Donnelly
2. RoundTable Healthcare Partners and Argon Medical Devices to Acquire Angiotech Pharmaceuticals Interventional Products Business
3. RoundTable Healthcare Partners Announces Sale of Aspen Surgical Products Holding, Inc. to Hill-Rom Holdings, Inc.
4. RoundTable Healthcare Partners Portfolio Company, Renaissance Acquisition Holdings, LLC Acquires DPT Laboratories
5. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
6. West Celebrates 90 Years of Healthcare Innovation
7. NYC Rehab Center Consortium CentersHealthcare.com Spotlights Social Workers Appreciation Month
8. Northstar announces that its much-anticipated pet healthcare product will go on sale April 17th
9. Dynamic Healthcare Services Announces David Erb as Director of Sales
10. Healthcare Coalitions Across the Nation Band Together to Ready for Disasters
11. Healthcare Tech developers ENuke Software LLC proud to announce completion of eBroselowLutens Artemis in Dutch, German, Portugese and Spanish
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... March 29, 2017 Varian Medical Systems (NYSE: ... for the second quarter of fiscal year 2017 following the ... news release will be followed by a teleconference available to ... and a link to the conference call webcast will be ... access the teleconference call and replay: ...
(Date:3/29/2017)... , March 29, 2017   Royal Philips ... in health technology, and PathAI, a company that ... with the aim to develop solutions that improve ... cancer and other diseases. The partnership aims to ... this form of artificial intelligence to be applied ...
(Date:3/29/2017)... TEL AVIV, Israel , March 29, 2017 ... license agreement in which Exeltis will obtain exclusive marketing rights for ... ... is an age-appropriate drug targeted to treat sleep disorders in children ... to be the first sleep medication approved for children. ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... Based on research from Guardian’s ... face in trying to balance both short-term and long-term benefits demands. Are ... the growing complexity, companies are finding that the short-term strategies used to control ...
(Date:3/29/2017)... ... March 29, 2017 , ... Altima Technologies, Inc., ... network and data center assets and audio-video devices has recently updated its Visio ... shapes for free and download shapes and stencils from http://www.VisioStencils.com. , ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... ... 29, 2017 , ... AvePoint , the Microsoft Cloud expert, is pleased ... Virginia, located at the Riverfront Plaza, 901 East Byrd Street. AvePoint is celebrating with ... S. Northam and Mayor of Richmond Levar M. Stoney. , Founded in 2001, AvePoint ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
Breaking Medicine News(10 mins):